U.S. Markets close in 2 hrs 49 mins

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
132.28-1.57 (-1.17%)
As of 1:10PM EDT. Market open.
People also watch
GILDBIIBREGNAMGNALXN
Full screen
Previous Close133.85
Open133.72
Bid132.34 x 300
Ask132.40 x 100
Day's Range132.22 - 133.85
52 Week Range96.06 - 135.18
Volume1,489,769
Avg. Volume3,819,760
Market Cap103.29B
Beta1.51
PE Ratio (TTM)49.67
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • 24/7 Wall St.4 hours ago

    Major Biotech Short Interest Surges

    The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.

  • Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone
    Investor's Business Daily21 hours ago

    Biotech Stock With 497% Growth, Positive Trial Results Nears Buy Zone

    With biotech stocks like Celgene, Bluebird Bio and Regeneron on the move, cancer treatment developer Exelixis may be poised to pop into a new buy zone.

  • Barrons.com22 hours ago

    Seattle Genetics: A Disappointing Study…Or Was It?

    Shares of Seattle Genetics (SGEN) are moving lower today, falling more than 9% after the drug maker’s experimental lymphoma drug failed to impress. The data from the late-stage study testing Adcetris, co-developed with Japan's Takeda Pharmaceutical, helped blood cancer patients live longer without worsening their conditions, meeting its endpoint. Altogether, lots of uncertainty whether these data could support a robust commercial adoption.